MyAverix Finance
US · Healthcare
Generate Biomedicines, Inc. Common Stock (GENB)
Biotechnology
Generate Biomedicines, Inc. Common Stock (GENB) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GENB
Generate Biomedicines, Inc. Common Stock (GENB) — FAQ
What is GENB's P/E ratio?
The price-to-earnings (P/E) ratio for Generate Biomedicines, Inc. Common Stock (GENB) is 25.00 (data as of 2026-05-23).
Does Generate Biomedicines, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Generate Biomedicines, Inc. Common Stock (GENB). Check the MyAverix Finance app for the latest dividend data.
What sector is Generate Biomedicines, Inc. Common Stock in?
Generate Biomedicines, Inc. Common Stock (GENB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is GENB listed on?
GENB is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.